Attenuation of apoptosis in enterocytes by blockade of potassium channels

Anatoly Grishin, Henri Ford, Jin Wang, Hui Li, Vicenta Salvador-Recatala, Edwin S. Levitan, Elena Zaks-Makhina

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Apoptosis plays an important role in maintaining the balance between proliferation and cell loss in the intestinal epithelium. Apoptosis rates may increase in intestinal pathologies such as inflammatory bowel disease and necrotizing enterocolitis, suggesting pharmacological prevention of apoptosis as a therapy for these conditions. Here, we explore the feasibility of this approach using the rat epithelial cell line IEC-6 as a model. On the basis of the known role of K+ efflux in apoptosis in various cell types, we hypothesized that K+ efflux is essential for apoptosis in enterocytes and that pharmacological blockade of this efflux would inhibit apoptosis. By probing intracellular [K+] with the K+-sensitive fluorescent dye and measuring the efflux of 86Rb+, we found that apoptosis-inducing treatment with the proteasome inhibitor MG-132 leads to a twofold increase in K+ efflux from IEC-6 cells. Blockade of K+ efflux with tetraethylammonium, 4-aminopyridine, stromatoxin, chromanol 293B, and the recently described K+ channel inhibitor 48F10 prevents DNA fragmentation, caspase activation, release of cytochrome c from mitochondria, and loss of mitochondrial membrane potential. Thus K+ efflux occurs early in the apoptotic program and is required for the execution of later events. Apoptotic K+ efflux critically depends on activation of p38 MAPK. These results demonstrate for the first time the requirement of K+ channel-mediated K+ efflux for progression of apoptosis in enterocytes and suggest the use of K+ channel blockers to prevent apoptotic cell loss occurring in intestinal pathologies.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume289
Issue number5 52-5
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Enterocytes
Potassium Channels
Apoptosis
Pharmacology
Pathology
4-Aminopyridine
Necrotizing Enterocolitis
Proteasome Inhibitors
Tetraethylammonium
Mitochondrial Membrane Potential
p38 Mitogen-Activated Protein Kinases
DNA Fragmentation
Intestinal Mucosa
Caspases
Cytochromes c
Fluorescent Dyes
Inflammatory Bowel Diseases
Mitochondria
Epithelial Cells
Cell Proliferation

Keywords

  • Apoptotic K efflux
  • IEC-6 cells
  • Intestinal pathologies
  • p38 mitogen-activated protein kinase

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Attenuation of apoptosis in enterocytes by blockade of potassium channels. / Grishin, Anatoly; Ford, Henri; Wang, Jin; Li, Hui; Salvador-Recatala, Vicenta; Levitan, Edwin S.; Zaks-Makhina, Elena.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 289, No. 5 52-5, 01.11.2005.

Research output: Contribution to journalArticle

Grishin, Anatoly ; Ford, Henri ; Wang, Jin ; Li, Hui ; Salvador-Recatala, Vicenta ; Levitan, Edwin S. ; Zaks-Makhina, Elena. / Attenuation of apoptosis in enterocytes by blockade of potassium channels. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2005 ; Vol. 289, No. 5 52-5.
@article{53a3f9a20e68437fbf3673398585c2dd,
title = "Attenuation of apoptosis in enterocytes by blockade of potassium channels",
abstract = "Apoptosis plays an important role in maintaining the balance between proliferation and cell loss in the intestinal epithelium. Apoptosis rates may increase in intestinal pathologies such as inflammatory bowel disease and necrotizing enterocolitis, suggesting pharmacological prevention of apoptosis as a therapy for these conditions. Here, we explore the feasibility of this approach using the rat epithelial cell line IEC-6 as a model. On the basis of the known role of K+ efflux in apoptosis in various cell types, we hypothesized that K+ efflux is essential for apoptosis in enterocytes and that pharmacological blockade of this efflux would inhibit apoptosis. By probing intracellular [K+] with the K+-sensitive fluorescent dye and measuring the efflux of 86Rb+, we found that apoptosis-inducing treatment with the proteasome inhibitor MG-132 leads to a twofold increase in K+ efflux from IEC-6 cells. Blockade of K+ efflux with tetraethylammonium, 4-aminopyridine, stromatoxin, chromanol 293B, and the recently described K+ channel inhibitor 48F10 prevents DNA fragmentation, caspase activation, release of cytochrome c from mitochondria, and loss of mitochondrial membrane potential. Thus K+ efflux occurs early in the apoptotic program and is required for the execution of later events. Apoptotic K+ efflux critically depends on activation of p38 MAPK. These results demonstrate for the first time the requirement of K+ channel-mediated K+ efflux for progression of apoptosis in enterocytes and suggest the use of K+ channel blockers to prevent apoptotic cell loss occurring in intestinal pathologies.",
keywords = "Apoptotic K efflux, IEC-6 cells, Intestinal pathologies, p38 mitogen-activated protein kinase",
author = "Anatoly Grishin and Henri Ford and Jin Wang and Hui Li and Vicenta Salvador-Recatala and Levitan, {Edwin S.} and Elena Zaks-Makhina",
year = "2005",
month = "11",
day = "1",
doi = "10.1152/ajpgi.00001.2005",
language = "English (US)",
volume = "289",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "5 52-5",

}

TY - JOUR

T1 - Attenuation of apoptosis in enterocytes by blockade of potassium channels

AU - Grishin, Anatoly

AU - Ford, Henri

AU - Wang, Jin

AU - Li, Hui

AU - Salvador-Recatala, Vicenta

AU - Levitan, Edwin S.

AU - Zaks-Makhina, Elena

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Apoptosis plays an important role in maintaining the balance between proliferation and cell loss in the intestinal epithelium. Apoptosis rates may increase in intestinal pathologies such as inflammatory bowel disease and necrotizing enterocolitis, suggesting pharmacological prevention of apoptosis as a therapy for these conditions. Here, we explore the feasibility of this approach using the rat epithelial cell line IEC-6 as a model. On the basis of the known role of K+ efflux in apoptosis in various cell types, we hypothesized that K+ efflux is essential for apoptosis in enterocytes and that pharmacological blockade of this efflux would inhibit apoptosis. By probing intracellular [K+] with the K+-sensitive fluorescent dye and measuring the efflux of 86Rb+, we found that apoptosis-inducing treatment with the proteasome inhibitor MG-132 leads to a twofold increase in K+ efflux from IEC-6 cells. Blockade of K+ efflux with tetraethylammonium, 4-aminopyridine, stromatoxin, chromanol 293B, and the recently described K+ channel inhibitor 48F10 prevents DNA fragmentation, caspase activation, release of cytochrome c from mitochondria, and loss of mitochondrial membrane potential. Thus K+ efflux occurs early in the apoptotic program and is required for the execution of later events. Apoptotic K+ efflux critically depends on activation of p38 MAPK. These results demonstrate for the first time the requirement of K+ channel-mediated K+ efflux for progression of apoptosis in enterocytes and suggest the use of K+ channel blockers to prevent apoptotic cell loss occurring in intestinal pathologies.

AB - Apoptosis plays an important role in maintaining the balance between proliferation and cell loss in the intestinal epithelium. Apoptosis rates may increase in intestinal pathologies such as inflammatory bowel disease and necrotizing enterocolitis, suggesting pharmacological prevention of apoptosis as a therapy for these conditions. Here, we explore the feasibility of this approach using the rat epithelial cell line IEC-6 as a model. On the basis of the known role of K+ efflux in apoptosis in various cell types, we hypothesized that K+ efflux is essential for apoptosis in enterocytes and that pharmacological blockade of this efflux would inhibit apoptosis. By probing intracellular [K+] with the K+-sensitive fluorescent dye and measuring the efflux of 86Rb+, we found that apoptosis-inducing treatment with the proteasome inhibitor MG-132 leads to a twofold increase in K+ efflux from IEC-6 cells. Blockade of K+ efflux with tetraethylammonium, 4-aminopyridine, stromatoxin, chromanol 293B, and the recently described K+ channel inhibitor 48F10 prevents DNA fragmentation, caspase activation, release of cytochrome c from mitochondria, and loss of mitochondrial membrane potential. Thus K+ efflux occurs early in the apoptotic program and is required for the execution of later events. Apoptotic K+ efflux critically depends on activation of p38 MAPK. These results demonstrate for the first time the requirement of K+ channel-mediated K+ efflux for progression of apoptosis in enterocytes and suggest the use of K+ channel blockers to prevent apoptotic cell loss occurring in intestinal pathologies.

KW - Apoptotic K efflux

KW - IEC-6 cells

KW - Intestinal pathologies

KW - p38 mitogen-activated protein kinase

UR - http://www.scopus.com/inward/record.url?scp=27444435091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27444435091&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00001.2005

DO - 10.1152/ajpgi.00001.2005

M3 - Article

C2 - 16020659

AN - SCOPUS:27444435091

VL - 289

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 5 52-5

ER -